Bristol-Myers Squibb
BMY
#192
Rank
NZ$208.17 B
Marketcap
NZ$101.94
Share price
3.85%
Change (1 day)
35.30%
Change (1 year)

Bristol-Myers Squibb (BMY) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$82.28 Billion

According to Bristol-Myers Squibb's latest financial reports the company's total debt is NZ$82.28 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bristol-Myers Squibb - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31NZ$81.39 B-10.34%
2024-12-31NZ$90.78 B38.46%
2023-12-31NZ$65.56 B2.24%
2022-12-31NZ$64.13 B-3.93%
2021-12-31NZ$66.75 B-6.79%
2020-12-31NZ$71.61 B1.46%
2019-12-31NZ$70.58 B544.26%
2018-12-31NZ$10.95 B-2.27%
2017-12-31NZ$11.21 B15.77%
2016-12-31NZ$9.68 B-0.91%
2015-12-31NZ$9.77 B-2.23%
2014-12-31NZ$9.99 B-1.51%
2013-12-31NZ$10.14 B12.91%
2012-12-31NZ$8.98 B27.75%
2011-12-31NZ$7.03 B-0.31%
2010-12-31NZ$7.05 B-19.41%
2009-12-31NZ$8.75 B-24.58%
2008-12-31NZ$11.61 B41.82%
2007-12-31NZ$8.18 B-22.41%
2006-12-31NZ$10.55 B-16.07%
2005-12-31NZ$12.57 B-13.27%
2004-12-31NZ$14.49 B7.67%
2003-12-31NZ$13.46 B-7.75%
2002-12-31NZ$14.59 B-5.44%
2001-12-31NZ$15.43 B356.73%
2000-12-31NZ$3.38 B-0.42%
1999-12-31NZ$3.39 B-3.09%
1998-12-31NZ$3.50 B11.56%
1997-12-31NZ$3.13 B49.98%
1996-12-31NZ$2.09 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$97.45 B 18.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$83.29 B 1.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$112.94 B 37.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$129.12 B 56.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$76.86 B-6.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$101.59 B 23.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$41.06 B-50.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$11.62 B-85.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$87.05 B 5.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$60.11 B-26.94%๐Ÿ‡ฌ๐Ÿ‡ง UK